Update What you have helped us achieve so far Our medical cannabis registry, Project Twenty21, was originally designed to run until the end of 2021 (hence the name). As you will know from your own life during the pandemic, the last two years have been full of challenges and obstacles. Project Twenty21 has navigated the …
Drug Science Response to the UKs 10-Year Drug Strategy Drug Science welcomes the fact that the government has agreed to accept many aspects of the Dame Carol Black review on addiction treatment services, to which Drug Science previously submitted evidence. The major positive outcome appears to be a focus on the use of treatments rather …
Two Years of Research Drug Science research, conducted over the past two years and in close collaboration with the affected families, clearly shows the immense benefits of medical cannabis treatment for these patients. In contrast to the current BPNA guidance stating that prescribing medical cannabis is probably not in the best interests of children, our …
Medical Cannabis is Legal in the UK? Medical Cannabis is legal in the United Kingdom, but you’d be forgiven for thinking that it was still prohibited. Access to treatment with medical cannabis has been shamefully slow, and even 3 years on, only 3 prescriptions have ever been issued under the NHS. The Path to Medical …
Summary Full Report Survey Data Does the UK support psilocybin research? Public perceptions of psilocybin-assisted therapy have been revealed in a new YouGov poll, commissioned by Drug Science. This is the first nationally representative poll of UK attitudes towards the medicalisation of psilocybin and support for policy changes (such as rescheduling psilocybin) to make this …
Authors Rayyan Zafar, Anne Katrin Schlag, Larry Phillips, David Nutt Published N/A Despite medical cannabis being legalised in 2018 thanks to a campaign by parents of children diagnosed with severe epilepsy, 3 years on regulations are still blocking access to an NHS prescription for the vast majority of children affected by the same condition. However, …
Authors C. Sakal, M. Lynskey, A. K. Schlag, D. J. Nutt Published May 11, 2021 We’re delighted to announce the first findings from Project Twenty21, the UK’s largest-ever medical cannabis patient study. Over 900 patients have now received licensed prescriptions for medical cannabis and agreed for Drug Science to collect and analyse their medical data …
A Closer Look at the Families Struggling to Cope with the Huge Financial and Personal Burden of Accessing Medical Cannabis to Treat Childhood Epilepsy By Danielle Johnson, Clinical Scientist in Neurophysiology and member of the Medical Cannabis Working Group at Drug Science In recent years, the case for medical cannabis as a treatment for drug-resistant …
On October 13th 2020, the MPWG hosted its first symposium entitled ‘Women in Psychedelic Science’, showcasing the ground-breaking and outstanding work of women in psychedelics. This was accompanied by inspiring, personal accounts of women who have used psychedelics to treat trauma. Psychedelic therapy – Clinical trials: Dr Meg Spriggs – Psilocybin for Anorexia Nervosa Laura …